Tasmar (tolcapone) for Parkinson's

March 1998

Roche is now marketing Tasmar (tolcapone) for Parkinson's. It'll be used with levodopa...for advanced Parkinson's.

Tasmar is the first drug in a new class...COMT inhibitors.

COMT (catechol-O-methyltransferase) is an enzyme that metabolizes levodopa to an INACTIVE metabolite. Blocking this enzyme increases the half-life of levodopa and prolongs its effect.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Hear a lot more about homocysteine
Venastat to relieve leg swelling due to varicose veins
Singulair (montelukast) for asthma
Serevent is approved for treating chronic obstructive pulmonary disease (COPD)
Obesity & Weight Loss New obesity drug, Meridia
Cardiology New combination antihypertensive called Teczem
Cardiology Whether patients can still take erythromycin before dental procedures to prevent bacterial endocarditis
Neurology & Pain New oral migraine drug, Amerge
Neurology & Pain Tasmar (tolcapone) for Parkinson's
Women's Health New strength of Prempro
Women's Health Topical testosterone for libido
Gastroenterology PrevPac, a new kit for H. pylori
Diabetes Boxed warning about which patients shouldn't take metformin (Glucophage)
Diabetes Another new drug for type 2 diabetes, called Prandin (repaglinide)
STIs New STD treatment guidelines
Poison Prevention National Poison Prevention Week is this month

Tasmar (tolcapone) for Parkinson's

Practical advice for a better career, with unlimited access to CE

Table of Contents